Ashland Global Holdings Inc. Leadership & Management

Key Insight for Candidates

• Strategic Vision & Planning: Leadership consistently articulates a focused specialty-chemicals strategy built around execute, globalize, and innovate, reinforced by priorities such as safety, innovation, productivity, and cash generation. The direction is repeatedly communicated and aligned with concentrating the portfolio on higher-value businesses in life sciences and personal care.
• Purposeful Goal Setting: Management ties its strategy to defined objectives, including approximately $30 million in fiscal 2026 cost savings and a $35 million combined revenue goal from the Globalize and Innovate platforms. Sales and adjusted EBITDA targets for fiscal 2026 have also been specified and updated as conditions evolve.
• Open & Transparent Communication: Leaders openly acknowledge shortfalls in operating performance and name stabilizing manufacturing execution as an immediate priority. Communications consistently reiterate the same strategic pillars and attach measurable goals, aiding clarity.

• Poor Execution: Operating performance has been uneven, with manufacturing disruptions, slower productivity at Hopewell, and challenges at Calvert City weighing on margins and prompting reduced fiscal 2026 guidance. Stabilizing plant reliability, controlling costs, and converting innovation into sustained earnings remain unresolved tasks.
• Lack of Transparency & Communication: Shifting directions and frequent reorganizations have created uncertainty and a desire for more precise communication about corporate changes. Leadership at times is described as disconnected from day-to-day operations or slower to implement changes in a clearly transparent manner.
• Unclear or Misaligned Goals: Perceived inconsistency in long-term direction has made it harder to map career progression amid reorganizations. This signals that strategic intentions are not always translated into clear, aligned goals across the organization.